Effects of tyrosine kinase inhibitors on voltage-dependent Ba2+ currents in the guinea-pig gastric antrum

Journal of Physiology and Pharmacology

Volumn 57, Issue 3, 2006, Pages 415-424

  Zhu, Hai Lei ^a   Ito, Yushi ^a   Teramoto, Noriyoshi ^a  

^a KYUSHU UNIVERSITY   (Japan)

Author keywords

Gastric smooth muscle; Tyrosine kinases; Voltage dependent Ca2+ channels

Indexed keywords

BARIUM DERIVATIVE; DAIDZEIN; GENISTEIN; LAVENDUSTIN A; PROTEIN TYROSINE KINASE; PROTEIN TYROSINE KINASE INHIBITOR; TYRPHOSTIN; VOLTAGE GATED CALCIUM CHANNEL;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CALCIUM MOBILIZATION; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG MECHANISM; NONHUMAN; SMOOTH MUSCLE FIBER; STOMACH ANTRUM; VOLTAGE CLAMP;

ANIMALS; BARIUM; CALCIUM CHANNELS; GENISTEIN; GUINEA PIGS; ION CHANNELS; MEMBRANE POTENTIALS; MYOCYTES, SMOOTH MUSCLE; PATCH-CLAMP TECHNIQUES; PROTEIN KINASE INHIBITORS; PROTEIN-TYROSINE KINASES; PYLORIC ANTRUM;

EID: 33749595039     PISSN: 08675910     EISSN: 08675910     Source Type: Journal    
DOI: None     Document Type: Article

References (24)

1. Davis MJ, Wu X, Nurkiewicz TR, Kawasaki J, Gui P, Hill MA, Wilson E. Regulation of ion channels by protein tyrosine phosphorylation. Am J Physiol 2001; 281:H1835-H1862.
2. Akbarali HI. Signal-transduction pathways that regulate smooth muscle function II. Receptor-ion channel coupling mechanisms in gastrointestinal smooth muscle. Am J Physiol 2005; 288:G598-G602.
3. Chiang CE, Chen SA, Chang MS, Lin CI, Luk HN. Genistein directly inhibits L-type calcium currents but potentiates cAMP-dependent chloride currents in cardiomyocytes. Biochem Biophys Res Commun 1996; 223:598-603.
4. Yokoshiki H, Sumii K, Sperelakis N. Inhibition of L-type calcium current in rat ventricular cells by the tyrosine kinase inhibitor, genistein and its inactive analog, daidzein. J Mol Cell Cardiol 1996; 28:807-814.
5. 2+ channel currents in NG108-15 cells. Pflügers Arch 1998; 436:127-132.
6. 2+ current in guinea pig ventricular myocytes treated with modulators of tyrosine phosphorylation. Am J Physiol 1999; 276:H1724-H1733.
7. Wijetunge S, Aalkjaer C, Schachter M, Hughes AD. Tyrosine kinase inhibitors block calcium channel currents in vascular smooth muscle cells. Biochem Biophys Res Commun 1992; 189:1620-1623.
8. 2+ channels in rabbit colonic smooth muscle cells by c-Src and focal adhesion kinase. J Biol Chem 1998; 273:5337-5342.
9. Hollenberg MD. Tyrosine kinase pathways and the regulation of smooth muscle contractility. Trends Pharmacol Sci 1994; 15:108-114.
10. Yang SG, Saifeddine M, Laniyonu A, Hollenberg MD. Distinct signal transduction pathways for angiotensin-II in guinea pig gastric smooth muscle: differential blockade by indomethacin and tyrosine kinase inhibitors. J Pharmacol Exp Ther 1993; 264:958-966.
11. McFadzean I, Gibson A. The developing relationship between receptor-operated and storeoperated calcium channels in smooth muscle. Br J Pharmacol 2002; 135:1-13.
12. 2+ currents in the guinea-pig gastric antrum by cyclic nucleotide-dependent pathways. Br J Pharmacol 2005; 146:129-138.
13. Teramoto N, Brading AF. Activation by levcromakalim and metabolic inhibition of glibenclamide-sensitive K channels in smooth muscle cells of pig proximal urethra. Br J Pharmacol 1996; 118:635-642.
14. 2+ channels in smooth muscle cells from pig proximal urethra. Br J Pharmacol 2005; 144:919-925.
15. Akiyama T, Ishida J, Nakagawa S, Ogawara H, Watanabe S, Itoh N, Shibuya M, Fukami Y. Genistein, a specific inhibitor of tyrosine-specific protein kinases. J Biol Chem 1987; 262:5592-5595.
16. Liu H, Li K, Sperelakis N. Tyrosine kinase inhibitor, genistein, inhibits macroscopic L-type calcium current in rat portal vein smooth muscle cells. Can J Physiol Pharmacol 1997; 75:1058-1062.
17. Wijetunge S, Hughes AD. Activation of endogenous c-Src or a related tyrosine kinase by intracellular (pY)EEI peptide increases voltage-operated calcium channel currents in rabbit ear artery cells. FEBS Lett 1996; 399:63-66.
18. Cataldi M, Taglialatela M, Guerriero S, Amoroso S, Lombardi G, di Renzo G, Annunziato L. Protein-tyrosine kinases activate while protein-tyrosine phosphatases inhibit L-type calcium channel activity in pituitary GH3 cells. J Biol Chem 1996; 271:9441-9446.
19. Mergler S, Dannowski H, Bednarz J, Engelmann K, Hartmann C, Pleyer U. Calcium influx induced by activation of receptor tyrosine kinases in SV40-transfected human corneal endothelial cells. Exp Eye Res 2003; 77:485-495.
20. Levitzki A, Gazit A. Tyrosine kinase inhibition: an approach to drug development. Science 1995; 267:1782-1788.
21. Rocchi S, Gaillard I, van Obberghen E, Chambaz EM, Vilgrain I. Adrenocorticotrophic hormone stimulates phosphotyrosine phosphatase SHP2 in bovine adrenocortical cells: phosphorylation and activation by cAMP-dependent protein kinase. Biochem J 2000; 352:483-490.
22. Blanco-Aparicio C, Torres J, Pulido R. A novel regulatory mechanism of MAP kinases activation and nuclear translocation mediated by PKA and the PTP-SL tyrosine phosphatase. J Cell Biol 1999; 147:1129-1136.
23. Saxena M, Williams S, Tasken K, Mustelin T. Crosstalk between cAMP-dependent kinase and MAP kinase through a protein tyrosine phosphatase. Nat Cell Biol 1999; 1:305-311.
24. 2+ channel activity via protein tyrosine phosphatase, not cAMP-dependent protein kinase. Mol Pharmacol 2003; 64:640-649.